[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Protalix Biotherapeutics (PLX)

Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,533
  • Shares Outstanding, K 80,572
  • Annual Sales, $ 52,740 K
  • Annual Income, $ -6,600 K
  • EBIT $ -6 M
  • EBITDA $ -4 M
  • 60-Month Beta -0.01
  • Price/Sales 3.06
  • Price/Cash Flow N/A
  • Price/Book 2.40

Options Overview Details

View History
  • Implied Volatility 69.63% (-37.13%)
  • Historical Volatility 38.03%
  • IV Percentile 4%
  • IV Rank 1.17%
  • IV High 1,386.23% on 07/10/25
  • IV Low 54.04% on 08/19/25
  • Expected Move (DTE 30) 0.6120 (32.04%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 52
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 7,958
  • Open Int (30-Day) 10,385
  • Expected Range 1.2980 to 2.5220

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.12
  • Number of Estimates 2
  • High Estimate $0.27
  • Low Estimate $-0.03
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8800 +1.60%
on 05/12/26
2.3000 -16.96%
on 04/20/26
-0.4100 (-17.67%)
since 04/17/26
3-Month
1.8800 +1.60%
on 05/12/26
3.1900 -40.13%
on 02/23/26
-1.0700 (-35.91%)
since 02/18/26
52-Week
1.3200 +44.70%
on 06/23/25
3.1900 -40.13%
on 02/23/26
+0.2400 (+14.37%)
since 05/16/25

Most Recent Stories

More News
Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results

Company to host conference call and webcast today at 8:00 a.m. EDT

PBD : 21.00 (-1.08%)
PLX : 1.9100 (-3.54%)
Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026

Company to host conference call and webcast at 8:00 a.m. EDT

PLX : 1.9100 (-3.54%)
Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

Company to host conference call and webcast today at 8:00 a.m. EDT

PLX : 1.9100 (-3.54%)
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026

Company to host conference call and webcast at 8:00 a.m. EDT

PLX : 1.9100 (-3.54%)
Protalix BioTherapeutics Letter to Stockholders

CARMIEL, Israel , Jan. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization...

PBD : 21.00 (-1.08%)
PLX : 1.9100 (-3.54%)
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement

Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator ® platform to jointly develop pharmaceutical candidates for rare renal indications...

PLX : 1.9100 (-3.54%)
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Company to host conference call and webcast today at 8:00 a.m. EST

PBD : 21.00 (-1.08%)
PLX : 1.9100 (-3.54%)
Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025

Company to host conference call and webcast at 8:00 a.m. EST

PLX : 1.9100 (-3.54%)
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. (“Protalix” or “the...

PLX : 1.9100 (-3.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. ("Protalix" or the "Company") (NYSE: PLX). Such investors...

PLX : 1.9100 (-3.54%)

Business Summary

Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.

See More

Key Turning Points

3rd Resistance Point 2.1567
2nd Resistance Point 2.1033
1st Resistance Point 2.0067
Last Price 1.9100
1st Support Level 1.8567
2nd Support Level 1.8033
3rd Support Level 1.7067

See More

52-Week High 3.1900
Fibonacci 61.8% 2.4757
Fibonacci 50% 2.2550
Fibonacci 38.2% 2.0343
Last Price 1.9100
52-Week Low 1.3200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.